Manager × security

Redmile Group, LLC RGNX holdings history

Who else holds this security? →

REGENXBIO INC · CUSIP 75901B107 · CIK 1425738

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Redmile Group, LLC reported 4.37M RGNX (shares), valued at $52.34M, or 3.51% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.51%
Shares
4.37M
4,368,804
Reported value
$52.34M
USD

Shares unchanged; reported value increased 42.96%, and weight changed +1.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.51%4,368,804SEC filing ↗Filed Aug 14, 2026
Q1 20262.42%4,368,804SEC filing ↗Filed May 15, 2026
Q4 20254.63%4,368,804SEC filing ↗Filed Feb 17, 2026
Q3 20254.41%4,693,389SEC filing ↗Filed Nov 14, 2025
Q2 20254.17%4,775,717SEC filing ↗Filed Aug 14, 2025
Q1 20253.24%4,794,780SEC filing ↗Filed May 15, 2025
Q4 20242.58%4,794,780SEC filing ↗Filed Feb 14, 2025
Q3 20243.02%4,892,902SEC filing ↗Filed Nov 14, 2024
Q2 20243.23%4,569,802SEC filing ↗Filed Aug 14, 2024
Q1 20243.52%4,551,556SEC filing ↗Filed May 15, 2024
Q4 20232.41%3,760,690SEC filing ↗Filed Feb 14, 2024
Q3 20232.02%2,574,042SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.02%2,574,042$42.37MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20232.41%3,760,690$67.50MShares increased 46.10%; reported value increased 59.33%, and weight changed +0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20243.52%4,551,556$95.90MShares increased 21.03%; reported value increased 42.07%, and weight changed +1.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20243.23%4,569,802$53.47MShares increased 0.40%; reported value decreased 44.25%, and weight changed -0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20243.02%4,892,902$51.33MShares increased 7.07%; reported value decreased 4.00%, and weight changed -0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20242.58%4,794,780$37.06MShares decreased 2.01%; reported value decreased 27.79%, and weight changed -0.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20253.24%4,794,780$34.28MShares unchanged; reported value decreased 7.50%, and weight changed +0.66 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20254.17%4,775,717$39.21MShares decreased 0.40%; reported value increased 14.37%, and weight changed +0.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20254.41%4,693,389$45.29MShares decreased 1.72%; reported value increased 15.51%, and weight changed +0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20254.63%4,368,804$62.91MShares decreased 6.92%; reported value increased 38.90%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20262.42%4,368,804$36.61MShares unchanged; reported value decreased 41.81%, and weight changed -2.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20263.51%4,368,804$52.34MShares unchanged; reported value increased 42.96%, and weight changed +1.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Redmile Group, LLC · REGENXBIO INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1425738","quarter":"2026Q2","cusip":"75901B107"}

get_institutional_manager_history
{"cik":"1425738","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.